150 related articles for article (PubMed ID: 7831631)
1. Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis.
Wallace WA; Schofield JA; Lamb D; Howie SE
Thorax; 1994 Nov; 49(11):1139-45. PubMed ID: 7831631
[TBL] [Abstract][Full Text] [Related]
2. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.
Wallace WA; Roberts SN; Caldwell H; Thornton E; Greening AP; Lamb D; Howie SE
Thorax; 1994 Mar; 49(3):218-24. PubMed ID: 8202877
[TBL] [Abstract][Full Text] [Related]
3. Detection of anti-cytokeratin 8 antibody in the serum of patients with cryptogenic fibrosing alveolitis and pulmonary fibrosis associated with collagen vascular disorders.
Dobashi N; Fujita J; Ohtsuki Y; Yamadori I; Yoshinouchi T; Kamei T; Tokuda M; Hojo S; Okada H; Takahara J
Thorax; 1998 Nov; 53(11):969-74. PubMed ID: 10193397
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis.
Egan JJ; Stewart JP; Hasleton PS; Arrand JR; Carroll KB; Woodcock AA
Thorax; 1995 Dec; 50(12):1234-9. PubMed ID: 8553293
[TBL] [Abstract][Full Text] [Related]
5. The immunological architecture of B-lymphocyte aggregates in cryptogenic fibrosing alveolitis.
Wallace WA; Howie SE; Krajewski AS; Lamb D
J Pathol; 1996 Mar; 178(3):323-9. PubMed ID: 8778339
[TBL] [Abstract][Full Text] [Related]
6. Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies.
Majumdar S; Li D; Ansari T; Pantelidis P; Black CM; Gizycki M; du Bois RM; Jeffery PK
Eur Respir J; 1999 Aug; 14(2):251-7. PubMed ID: 10515397
[TBL] [Abstract][Full Text] [Related]
7. Private specificities can dominate the humoral response to self-antigens in patients with cryptogenic fibrosing alveolitis.
Robinson C; Callow M; Stevenson S; Robinson BW; Lake RA
Respir Res; 2001; 2(2):119-24. PubMed ID: 11686873
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactive interleukin 4 and interferon-gamma expression by type II alveolar epithelial cells in interstitial lung disease.
Wallace WA; Howie SE
J Pathol; 1999 Mar; 187(4):475-80. PubMed ID: 10398109
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of tenascin and TGFbeta production in a type II alveolar epithelial cell line by antibody against a pulmonary auto-antigen.
Wallace WA; Howie SE
J Pathol; 2001 Sep; 195(2):251-6. PubMed ID: 11592106
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease.
Meliconi R; Bestagno M; Sturani C; Negri C; Galavotti V; Sala C; Facchini A; Ciarrocchi G; Gasbarrini G; Astaldi Ricotti GC
Clin Exp Immunol; 1989 May; 76(2):184-9. PubMed ID: 2547538
[TBL] [Abstract][Full Text] [Related]
11. Tenascin immunoreactivity in cryptogenic fibrosing alveolitis.
Wallace WA; Howie SE; Lamb D; Salter DM
J Pathol; 1995 Apr; 175(4):415-20. PubMed ID: 7540684
[TBL] [Abstract][Full Text] [Related]
12. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA).
Wallace WA; Ramage EA; Lamb D; Howie SE
Clin Exp Immunol; 1995 Sep; 101(3):436-41. PubMed ID: 7664490
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of alveolitis by studies of lung biopsies.
Haslam PL
Lung; 1990; 168 Suppl():984-92. PubMed ID: 2117219
[TBL] [Abstract][Full Text] [Related]
14. Impaired antibody-dependent cell-mediated cytotoxicity in cryptogenic fibrosing alveolitis (synonym: idiopathic pulmonary fibrosis).
Haslam PL; Allan F; Watling AF; Barrett C; Morris L; Turner-Warwick M
Clin Exp Immunol; 1982 Jul; 49(1):59-66. PubMed ID: 7127903
[TBL] [Abstract][Full Text] [Related]
15. Influence of human T lymphotrophic virus type I on cryptogenic fibrosing alveolitis - HTLV-I associated fibrosing alveolitis: proposal of a new clinical entity.
Matsuyama W; Kawabata M; Mizoguchi A; Iwami F; Wakimoto J; Osame M
Clin Exp Immunol; 2003 Sep; 133(3):397-403. PubMed ID: 12930367
[TBL] [Abstract][Full Text] [Related]
16. [Specific features of humoral immunity in cryptogenic fibrosing alveolitis patients].
Markina OA; Iastrebova NE; Vaneeva NP; Liashova VN
Zh Mikrobiol Epidemiol Immunobiol; 2004; (5):76-80. PubMed ID: 15554319
[TBL] [Abstract][Full Text] [Related]
17. Detection of anti-ADAM 10 antibody in serum of a patient with pulmonary fibrosis associated with dermatomyositis.
Fujita J; Takeuchi T; Dobashi N; Ohtsuki Y; Tokuda M; Takahara J
Ann Rheum Dis; 1999 Dec; 58(12):770-2. PubMed ID: 10577965
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary sarcoidosis mimicking cryptogenic fibrosing alveolitis on CT.
Padley SP; Padhani AR; Nicholson A; Hansell DM
Clin Radiol; 1996 Nov; 51(11):807-10. PubMed ID: 8937326
[TBL] [Abstract][Full Text] [Related]
19. Immunofluorescence studies of lung biopsy tissue.
Hogan PG; Donald KJ; McEvoy JD
Am Rev Respir Dis; 1978 Sep; 118(3):537-45. PubMed ID: 152076
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody to alanyl-tRNA synthetase in patients with idiopathic pulmonary fibrosis.
Takahashi T; Wada I; Ohtsuka Y; Munakata M; Homma Y; Kuroki Y
Respirology; 2007 Sep; 12(5):642-53. PubMed ID: 17875050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
